Epigallocatechin-3-gallate (EGCG) as a molecular chaperone and network rebalancer in neurodegenerative diseases.

Saved in:
Bibliographic Details
Title: Epigallocatechin-3-gallate (EGCG) as a molecular chaperone and network rebalancer in neurodegenerative diseases.
Authors: Farah H; Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. h.farah@ammanu.edu.jo., Ahmed MH; Department of Anesthesia Techniques, health and medical techniques college, Alnoor University, Mosul, Iraq., Al-Hasnaawei S; College of pharmacy, the Islamic University, Najaf, Iraq.; Department of medical analysis, Medical laboratory technique college, the Islamic University of Al Diwaniyah, Al Diwaniyah, Iraq., Malathi H; Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India., Mishra S; Department of Pharmacology, IMS and SUM Hospital, Siksha 'O' Anusandhan, Bhubaneswar, 751003, Odisha, India., Nanda A; Department of Biomedical, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India., Arora V; University institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India., Chauhan AS; Uttaranchal Institute of Pharmaceutical Sciences, Division of research and innovation, Uttaranchal University, Dehradun, Uttarakhand, India.
Source: Inflammopharmacology [Inflammopharmacology] 2026 Jun 15. Date of Electronic Publication: 2026 Jun 15.
Publication Type: Journal Article; Review
Journal Info: Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1568-5608 (Electronic) Linking ISSN: 09254692 NLM ISO Abbreviation: Inflammopharmacology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1568-5608
DOI:10.1007/s10787-026-02291-6